AMLN Amylin Pharmaceuticals, Inc. (MM)

SAN DIEGO, Sept. 19 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) today announced that Roger Marchetti will join the Company as Senior Vice President, Human Resources and Corporate Services. Mr. Marchetti will take over for Martin Brown, who will be retiring from Amylin in October. "We are very excited to welcome Roger to the Amylin team," said Ginger L. Graham, President and CEO of Amylin Pharmaceuticals. "His leadership and experience in the healthcare industry will be very valuable to Amylin as we build a leading biopharmaceutical company." Mr. Marchetti joins Amylin from Guidant Corporation, where he most recently served as Vice President, Human Resources. Prior to this role, he was Vice President, Finance and Information Systems, Guidant Europe, Middle East, Africa, and Canada. Mr. Marchetti also served as Vice President, Human Resources for Guidant's Vascular Intervention group and before that as Guidant's Corporate Controller and Chief Accounting Officer. Prior to Guidant, he served in various accounting positions at Advanced Cardiovascular Systems, Inc. (ACS), Eli Lilly and Company's Medical Devices and Diagnostics division and as Financial Manager for Lilly's pharmaceutical manufacturing operations in Indianapolis. Mr. Marchetti received his B.S. in Business Administration from LaSalle University and his MBA from the University of Michigan. He is a Certified Public Accountant, a member of the Financial Executives Institute, and serves on the corporate advisory board of the Stephen M. Ross School of Business at the University of Michigan. Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive Director, Investor Relations of Amylin Pharmaceuticals, Inc., +1-858-552-2200, ext. 7272 Web site: http://www.amylin.com/

Copyright